Fulcrum Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FULC and other ETFs, options, and stocks.

About FULC

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF.

CEO

Alexander C. Sapir

CEOAlexander C. Sapir

Employees

Employees45

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2015

Founded2015

Employees

Employees45

FULC Key Statistics

Market cap

348.17M

Market cap348.17M

Price-Earnings ratio

-97.57

Price-Earnings ratio-97.57

Dividend yield

—

Dividend yield—

Average volume

410.08K

Average volume410.08K

High today

$6.87

High today$6.87

Low today

$6.33

Low today$6.33

Open price

$6.78

Open price$6.78

Volume

679.77K

Volume679.77K

52 Week high

$10.13

52 Week high$10.13

52 Week low

$2.32

52 Week low$2.32

Analyst ratings

57%

of 7 ratings

Buy

57.1%

Hold

28.6%

Sell

14.3%

People also own

Based on the portfolios of people who own FULC. This list is generated using Robinhood data, and it’s not a recommendation.